Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer

Annika Jögi(Lund University), Karin Jirström(Lund University)
Modern Pathology
September 4, 2009
10.1038/modpathol.2009.124
Cited by 85

Related Papers

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
|British Journal of Cancer|2013|75
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
|PLoS ONE|2019|72
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
|Oncotarget|2017|62
Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
|Frontiers in Oncology|2019|45
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells
|Oncotarget|2016|22